Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)
Clinical trial NCT04502082 · TERMINATED
Trial details
- NCT number
- NCT04502082
- Sponsor
- Eureka Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2024-08-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.